Shengnuo pharmaceutical-b (02257. HK) announced that the over allotment right described in the prospectus had been partially exercised by the joint representatives (for itself and on behalf of the International Underwriters) on January 21, 2022, involving a total of 97345 shares, equivalent to about 12.91% of the total number of offer shares initially available for subscription under the global offering before the exercise of any over allotment right.
The over allotted shares will be allotted and issued by the company at the price of HK $65.90 per share (i.e. the offer price per share under the global offering, excluding 1% brokerage commission, 0.0027% SFC transaction levy, 0.005% SEHK transaction fee and 0.00015% FRC transaction levy). The over allotment of shares will be used to facilitate the delivery of part of the relevant shares to Kunming jiashiqing, the cornerstone investor who has agreed to delay the delivery of 1131000 shares subscribed by it in accordance with the relevant cornerstone investment agreement.
The company further announced that the stable price period for the global offering had ended on January 22, 2022 ( Saturday Co.Ltd(002291) ) (i.e. the 30th day after the deadline for submission of Hong Kong public offering applications). Immediately after the completion of the issuance of shares under the partial exercise of the over allotment right, the company will continue to comply with rules 8.08 (1) (a) and 18a of the listing rules Provisions on public shareholding in article 07.
